Skip to main content
MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199
Published Web Location
http://europepmc.org/articles/PMC4700051?pdf=renderNo data is associated with this publication.